This information was originally presented at the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida.

Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death.

Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death.

Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death.

Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death.

Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death.

As treatment paradigms improve and young women live longer after a breast cancer diagnosis, there is an increasing need to define the fertility-related problems that premenopausal women with breast cancer face, and, more importantly, to find solutions.

Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death.

Join Michael Berry, MD and Lee Schwartzberg, MD from The University of Tennessee Health Science Center as they present their multidisciplinary expertise on a range of cases pertaining to hormone sensitive breast cancer.

The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling and risk assessment and management for hereditary cancer syndromes.